Ignite Creation Date:
2024-05-06 @ 1:18 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03980483
Status:
COMPLETED
Last Update Posted:
2024-03-27
First Post:
2019-05-15
Brief Title:
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-16
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-16
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-15
First Submit QC Date:
June 7 2019
Study First Post Date:
2019-06-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-10-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2022-08-05
Disp First Submit QC Date:
September 29 2023
Disp First Post Date:
2023-10-25
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-03-26
Last Update Post Date:
2024-03-27
Last Update Post Date Type:
ACTUAL